The Minimal Clinically Important Difference for the “Patient Activation Measure”

Introduction: Patient activation is the knowledge, skills, and confidence required to manage one’s own health. In chronic kidney disease (CKD), the most frequently used measure of patient activation is the 13-item “Patient Activation Measure” (PAM-13). To help better determine an intervention's...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteurs:	Thomas J. Wilkinson, Devika Nair, Alice C. Smith, Gurneet K. Sohansoha, Ella C. Ford, Noemi Vadaszy, Matthew Graham-Brown, Courtney J. Lightfoot
Formaat:	Artikel
Taal:	Engels
Gepubliceerd in:	Elsevier 2025-07-01
Reeks:	Kidney International Reports
Onderwerpen:	kidney disease minimal clinically important difference patient activation measure quality of life self-management
Online toegang:	http://www.sciencedirect.com/science/article/pii/S2468024925002694
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Wees de eerste die reageert!

The Minimal Clinically Important Difference for the “Patient Activation Measure”

Gelijkaardige items